Burning Rock Biotech (BNR) Net Margin (2020 - 2025)
Historic Net Margin for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to 12.74%.
- Burning Rock Biotech's Net Margin rose 150600.0% to 12.74% in Q3 2025 from the same period last year, while for Sep 2025 it was 20.38%, marking a year-over-year increase of 631100.0%. This contributed to the annual value of 64.92% for FY2024, which is 567100.0% up from last year.
- According to the latest figures from Q3 2025, Burning Rock Biotech's Net Margin is 12.74%, which was up 150600.0% from 6.53% recorded in Q2 2025.
- Over the past 5 years, Burning Rock Biotech's Net Margin peaked at 6.53% during Q2 2025, and registered a low of 200.36% during Q2 2022.
- In the last 5 years, Burning Rock Biotech's Net Margin had a median value of 133.97% in 2023 and averaged 110.6%.
- Its Net Margin has fluctuated over the past 5 years, first crashed by -577000bps in 2021, then soared by 1106300bps in 2023.
- Burning Rock Biotech's Net Margin (Quarter) stood at 170.44% in 2021, then rose by 11bps to 152.02% in 2022, then increased by 12bps to 133.97% in 2023, then soared by 58bps to 56.07% in 2024, then soared by 77bps to 12.74% in 2025.
- Its Net Margin stands at 12.74% for Q3 2025, versus 6.53% for Q2 2025 and 10.15% for Q1 2025.